{"id":"W4206322108","doi":"10.1016/j.jval.2021.11.849","title":"POSA282 Oncology Drugs without Phase III Data: Comparison of Reimbursement Recommendations Issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Amgen (Canada); EVERSANA (Canada)","funders":"","keywords":"Nice; Reimbursement; Excellence; Medicine; Agency (philosophy); Family medicine; Clinical trial; Health care; Internal medicine; Oncology; Political science; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02740144,0.0006805246,0.002935807,0.001999672,0.0003769105,0.002752609,0.00153711,0.002099877,0.0111352],"category_scores_gemma":[0.05872118,0.0004451189,0.006275021,0.003205037,0.0006780412,0.001822265,0.00133631,0.00399895,0.00112699],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005085525,"about_ca_system_score_gemma":0.005186713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009090418,"about_ca_topic_score_gemma":0.01109939,"domain_scores_codex":[0.9798183,0.01241526,0.001847091,0.00111291,0.00405567,0.0007506743],"domain_scores_gemma":[0.9483518,0.03747513,0.007138968,0.001521305,0.00269535,0.002817479],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3786053,0.00122689,0.02422169,0.01098532,0.0240931,0.000280603,0.0002965808,0.02048214,0.001776066,0.01837689,0.170077,0.3495784],"study_design_scores_gemma":[0.1411936,0.02992248,0.3380763,0.009486661,0.04992487,0.001596166,0.001336715,0.02597066,0.003714383,0.01856919,0.3795457,0.0006632199],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5123661,0.188506,0.0138746,0.04434329,0.004659643,0.003557397,0.1078375,0.0007928444,0.1240626],"genre_scores_gemma":[0.926691,0.01439252,0.005878492,0.01340638,0.0007044143,0.0007674735,0.03330881,0.0003754358,0.004475525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9949145,"threshold_uncertainty_score":0.1449143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4356117424406482,"score_gpt":0.5090414548938318,"score_spread":0.07342971245318364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}